BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04113616-completion@plaintrial.com
DTSTAMP:20261028T235436Z
DTSTART;VALUE=DATE:20230927
SUMMARY:An Open-Label\, Multicenter\, Phase 1b/2 Study of the Safety and Ef
 ficacy of KRT-232 When Administered Alone and in Combination With Low-Dose
  Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (
 AML) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04113616
URL:https://plaintrial.com/trial/NCT04113616
END:VEVENT
END:VCALENDAR